Jujic A, Nilsson PM, Atabaki-Pasdar N, Dieden A, Tuomi T, Franks PW, Holst JJ, Torekov SS, Ravassa S, Diez J, et al
Standard practice includes: Baseline thyroid function tests (TSH and free T4) before initiating GLP-1 therapy Repeat testing at 812 weeks after starting treatment or after dose escalation Regular monitoring every 36 months during active weight loss Return to annual monitoring once weight is stable and thyroid function remains consistent Adjustments to levothyroxine dosing may be necessary as weight changes
SNAP-8 is applied topically and competes with SNAP-25 for SNARE assembly extracellularly
After TMB substrate solution is added, only those wells that contain Mouse LEP, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color
Tng mc nng lng, tng sc mnh v sc chu ng nn rt tt cho c th